0001209191-16-152668.txt : 20161201
0001209191-16-152668.hdr.sgml : 20161201
20161201160749
ACCESSION NUMBER: 0001209191-16-152668
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161130
FILED AS OF DATE: 20161201
DATE AS OF CHANGE: 20161201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 SOUTH STREET
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 86 SOUTH STREET
CITY: HOPKINTON
STATE: MA
ZIP: 01748
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Driscoll Martin J
CENTRAL INDEX KEY: 0001339402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 162028420
MAIL ADDRESS:
STREET 1: C/O JAVELIN PHARMACEUTICALS, INC.
STREET 2: 125 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-30
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001339402
Driscoll Martin J
C/O SPRING BANK PHARMACEUTICALS, INC.
86 SOUTH STREET
HOPKINTON
MA
01748
1
1
0
0
President and CEO
Common Stock
2016-11-30
4
P
0
2000
7.98
A
48400
D
/s/ Jonathan Freve, attorney-in-fact
2016-12-01